Moleculin Biotech risks Nasdaq delisting after shares stay below $1 bid threshold

Bitget2026/09/18 21:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Moleculin Biotech received a Nasdaq staff determination letter on Sept. 15, 2026, flagging noncompliance with the $1 minimum bid rule.
Shares closed below $1 for 30 straight business days from July 31, 2026 through Sept. 11, 2026.
Nasdaq denied the standard 180-day cure period due to a 1-for-25 reverse split on Dec. 1, 2025.
A timely hearing request will stay any suspension or delisting while the Nasdaq panel reviews the case.
Continued listing remains uncertain if the stock fails to regain and hold the $1 bid threshold.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-030757), on September 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Moleculin Biotech risks Nasdaq delisting after shares stay below $1 bid threshold

You may also like

Crypto prices